Healthcare Equipment and Supplies
Company Overview of B. Braun Melsungen AG
B. Braun Melsungen AG, together with its subsidiaries, manufactures, markets, and sells various healthcare products and services for intensive care units, anesthesia and emergency care, extracorporeal blood treatment, and surgical core procedures worldwide. The company’s Hospital Care division supplies IV sets and accessories, infusion and injection solutions, intravenous catheters, and clinical nutrition products, as well as pumps and associated systems; disposable medical and wound drainage products; pharmaceuticals and products for drug admixture and regional anesthesia; and automated infusion systems. Its Aesculap division develops and distributes products and services in the areas of su...
Founded in 1839
Key Executives for B. Braun Melsungen AG
Chairman of Management Board and Director of Human Resources, Legal Affairs & Labor Relations
Chief Financial Officer and Member of Management Board
Member of Management Board and Chief Executive Officer of B Braun America
President of The Asia/Pacific Region and Deputy Member of Management Board
Senior Vice President of Corporate Communications & Knowledge Management
Compensation as of Fiscal Year 2016.
B. Braun Melsungen AG Key Developments
B. Braun Melsungen AG and ICU Medical, Inc. Sign Expanded Long-Term International Distribution Agreement
Mar 21 16
ICU Medical Inc. announced that it has entered into a long-term distribution agreement with B. Braun Melsungen AG, giving B. Braun distribution rights to promote ICU Medical's SwabCap® disinfecting cap for needlefree connectors in selected countries outside the United States. Under the expanded agreement, customers will be able to purchase the SwabCap family of products from B. Braun in more than 30 countries around the world. SwabCap is a disposable cap designed to disinfect needlefree connectors with 70% isopropyl alcohol when attached to an intravenous catheter. The device's patented design has been proven to help enhance the barrier to bacterial ingress while improving visual swabbing compliance in the process.
B. Braun Melsungen AG Appoints Anna Maria Braun to the Management Board, Effective April 1, 2016
Dec 14 15
B. Braun Melsungen AG has appointed Anna Maria Braun, president of the Asia/Pacific region, to the management board, effective April 1, 2016. In December 13, 2015 meeting the Supervisory Board of B. Braun Melsungen AG has appointed Anna Maria Braun, President of the Asia/Pacific region, as deputy member of the Management Board of the medtech and pharma company as of April 1, 2016. Anna Maria Braun has been directing the Malaysian subsidiary of B. Braun Melsungen AG, B. Braun Medical Industries Sdn. Bhd since 2013, and is as President Asia Pacific responsible for the business of the pharma and medtech company in the entire Asia-Pacific region. Previously, she had been conducting the Asian product business of the dialysis division B. Braun Avitum for two years.
B. Braun Melsungen AG Announces Earnings Results for the Fiscal Year of 2014; Provides Sales Guidance for the Fiscal 2015
Mar 27 15
B. Braun Melsungen AG announced earnings results for the fiscal year of 2014. The company booked record revenue in 2014 despite the negative currency effects. Revenue gained 5% on the year to EUR 5.43 billion (USD 5.87 billion) compared to EUR 5,169.5 million a year ago. Net profit grew only 0.3% to EUR 316.3 million due to negative currency effects of about EUR 85 million. EBITDA was EUR 798.4 million compared to EUR 784.9 million a year ago.
For fiscal 2015, the company expects further sales growth at constant exchange rates of between 4% and 6%.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|